Geez guys. Listen to the YouTube link provided by Bathurst, above. It's really worth a listen.
The CEO clearly stated they are already passing the marketing and driving of sales onto specialist in-house and outsourced companies to do this..
PIQ will have a blend of DTC and traditional licencing agreements, although DTC makes most sense as the margins are so much higher.
Diabetes and endometriosis have well established organisations, both government and private, that support patients who have these conditions, and they will be fully aware of these breakthrough diagnostics. Information will get to specialists in these areas and GP's as well. Sufferers do a lot of their own research via these and individuals online searches.That's where most of our business will come from.
Major re-rates from here will come when the Australian and US labs gets their accreditation, after which we can start sales, and then when we can start to see the penetration we can make in terms of revenue.
Still probably 6 months away from clarity on the later, but the plan is there, it is spelled out and now just needs executing.
Milesy
PIQ Price at posting:
66.0¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)